Pre-treatment with apigenin (50 μM) for 24 h significantly reduced caspase-3/7 activity levels of sporadic AD neurons (p < 0.001) to the level of control neurons (Fig. 4C). The gene discussed is CASP3; the disease is Alzheimer disease.